Dehaier Medical Systems Ltd  

(Public, NASDAQ:DHRM)   Watch this stock  
Find more results for DHRM
-0.03 (-0.91%)
Jan 30 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.73 - 2.79
52 week 2.49 - 12.89
Open 2.73
Vol / Avg. 12,418.00/45,715.00
Mkt cap 15.57M
P/E 6.49
Div/yield     -
EPS 0.43
Shares 5.62M
Beta 2.41
Inst. own 2%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 5.70% 11.88%
Operating margin 18.64% 20.79%
EBITD margin - 24.47%
Return on average assets 2.32% 4.98%
Return on average equity 2.61% 5.83%
Employees 104 -
CDP Score - -


No.45 Yongan Road Science Park, Changping District
+86-10-51660608 (Phone)
+86-10-89718090 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Dehaier Medical Systems Limited (Dehaier) designs, develops and markets its branded products in China. The Company imports the majority of the products and medical components it sells to its customers. The Company designs and develops some of the medical components that are part of the branded products to be distributed. Some of these medical components are manufactured by contractors in China because it does not have a manufacturing facility. Most of its branded products require light assembly. The Company focuses on the development and distribution of medical devices. In addition to Dehaier�s branded products, it also serves as a distributor of products designed and manufactured by other companies. The Company broadens product portfolio through distribution agreements with international manufacturers. In May 2012, the Company announced that it established a wholly owned United States subsidiary, BreathCare, LLC.

Officers and directors

Ping Chen Chairman of the Board, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
Huili Li Chief Financial Officer, Director
Bio & Compensation  - Reuters
Genhui Chen PhD Independent Director
Age: 49
Bio & Compensation  - Reuters
Yunxiang Fan Independent Director
Age: 47
Bio & Compensation  - Reuters
Mingwei Zhang Independent Director
Age: 59
Bio & Compensation  - Reuters